# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Feb 7, 2023

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2023-02-07
- Accepted by EDGAR: Feb 7, 2023, 16:07 ET
- Period: 2023-02-07
- Accession: 0000875320-23-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532023000004/vrtx-20230207.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532023000004/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532023000004/vrtx-20230207.htm

Filed Feb 7, 2023.
Source: SEC EDGAR, the filing index for accession 0000875320-23-000004. Last ingested by Listed: Nov 3, 2026, 18:50 ET. No prices; not investment advice.